Related Experiment Video
Updated: Feb 26, 2026

Mechanical Stimulation of Chondrocyte-agarose Hydrogels
Published on: October 27, 2012
Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1
K M Lawrence1, R C Jones2, T R Jackson2
1Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Sciences Centre, The University of Manchester, Wilmslow Road, Manchester, M20 4GJ, UK. kevin.lawrence@manchester.ac.uk.
Abstract:
Osteoarthritis (OA) is characterised by progressive destruction of articular cartilage and chondrocyte cell death. Here, we show the expression of the endogenous peptide urocortin1 (Ucn1) and two receptor subtypes, CRF-R1 and CRF-R2, in primary human articular chondrocytes (AC) and demonstrate its role as an autocrine/paracrine pro-survival factor. This effect could only be removed using the CRF-R1 selective antagonist CP-154526, suggesting Ucn1 acts through CRF-R1 when promoting chondrocyte survival. This cell death was characterised by an increase in p53 expression, and cleavage of caspase 9 and 3. Antagonism of CRF-R1 with CP-154526 caused an accumulation of intracellular calcium (Ca2+) over time and cell death. These effects could be prevented with the non-selective cation channel blocker Gadolinium (Gd3+). Therefore, opening of a non-selective cation channel causes cell death and Ucn1 maintains this channel in a closed conformation. This channel was identified to be the mechanosensitive channel Piezo1. We go on to determine that this channel inhibition by Ucn1 is mediated initially by an increase in cyclic adenosine monophosphate (cAMP) and a subsequent inactivation of phospholipase A2 (PLA2), whose metabolites are known to modulate ion channels. Knowledge of these novel pathways may present opportunities for interventions that could abrogate the progression of OA.
Insights
Urocortin1 (Ucn1) protects human chondrocytes from osteoarthritis (OA) by inhibiting the Piezo1 channel. This novel pathway involves cyclic adenosine monophosphate (cAMP) and phospholipase A2 (PLA2), offering potential OA intervention strategies.
Area of Science:
- Cell Biology
- Biochemistry
- Physiology
Background:
- Osteoarthritis (OA) involves articular cartilage destruction and chondrocyte death.
- The role of endogenous peptides in chondrocyte survival is not fully understood.
Purpose of the Study:
- To investigate the role of urocortin1 (Ucn1) and its receptors in human articular chondrocytes (AC).
- To elucidate the signaling pathways involved in Ucn1-mediated chondrocyte survival and cell death.
Main Methods:
- Primary human articular chondrocytes (AC) were used.
- Expression of Ucn1, CRF-R1, and CRF-R2 was analyzed.
- Selective antagonists (CP-154526) and blockers (Gadolinium) were employed.
- Intracellular calcium (Ca2+) levels, p53 expression, and caspase activity were measured.
- Mechanosensitive channel Piezo1 and cAMP/PLA2 pathways were investigated.
Main Results:
- Ucn1 acts as an autocrine/paracrine pro-survival factor in AC, primarily through CRF-R1.
- Antagonism of CRF-R1 led to chondrocyte cell death, increased intracellular Ca2+, and activation of p53 and caspases.
- Ucn1 inhibits the Piezo1 channel, preventing Ca2+ influx and cell death.
- Ucn1's inhibitory effect on Piezo1 is mediated by increased cAMP and subsequent PLA2 inactivation.
Conclusions:
- Urocortin1 (Ucn1) is a crucial pro-survival factor for human articular chondrocytes (AC).
- Ucn1 protects AC by inhibiting the mechanosensitive Piezo1 channel via a cAMP/PLA2-dependent mechanism.
- These findings reveal novel pathways in OA pathogenesis and suggest potential therapeutic targets for OA intervention.
Related Concept Videos
Mechanically-gated Ion Channels
Hedgehog Signaling Pathway
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
GPCRs Regulate Adenylyl Cylase Activity

